Reference : Sustained antihypertensive activity of telmisartan compared vs valsartan
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : Urology & nephrology
Sustained antihypertensive activity of telmisartan compared vs valsartan
Lacourcière, Yves mailto [CRCHUQ Québec (Québec), Canada > > Métabolisme, santé vasculaire et rénale > >]
Krzesinski, Jean-Marie mailto [Université de Liège - ULiège > Département des sciences cliniques > Néphrologie >]
White, William B [University of Connecticut - UCONN > School of Medicine > > >]
Davidai, Giora [Boerhringer Ingelheim Pharmaceuticals Inc. > > > >]
Oostvotel, L. [Boehringer Ingelheim SA > > > >]
Schumacher, H. [Boehringer Ingelheim Pharma KG > > > >]
Journal of Hypertension. Supplement)
Lippincott Williams & Wilkins
suppl 1
Yes (verified by ORBi)
United Kingdom
20th Scientific Meeting of the International Society of Hypertension
15-19 février 2004
International Society of Hypertension
Sao Paulo
[en] Antihypertensive activity ; Telmisartan ; Valsartan ; BP control
[en] DBP reduction in the last 6 h of the once-daily dosing interval and 24-h mean DBP control when a dose is missed are significantly superior with telmisartan than with valsartan. Thus, telmisartan due to its longer half -life offers more sustained BP control, especially at the end of the dosing period and provides sustained efficacy in poorly compliant patients.

File(s) associated to this reference

Fulltext file(s):

Open access
J Hypertens 2004 22 suppl 1 S196 P724001.pdfPublisher postprint289.93 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.